Prostate Cancer - Results from #28720

ASCO 2008 Annual Meeting - Crossover Pharmacokinetics (PK) Study to Assess Oral Administration of Abiraterone Acetate Capsule and Tablet Formulations in Fasted and Fed States in Patients with Prostate Cancer August 13, 2008

ASCO 2008 Annual Meeting - Anti-Tumor Activity of Abiraterone Acetate (AA), a CYP17 Inhibitor of Androgen Synthesis, in Chemotherapy Naive and Docetaxel Pre-Treated Castration Resistant Prostate Cancer (CRPC) August 13, 2008

ASCO 2008 Annual Meeting - Abiraterone Acetate and Prednisone in Patients (Pts) with Progressive Metastatic Castration Resistant Prostate Cancer (CRPC) After Failure of Docetaxel-Based Chemotherapy August 13, 2008

The influence of developmental life stage on quality of life in survivors of prostate cancer and their partners - Abstract July 1, 2008

The Ultrastructure of Detrusor in Patients with Benign Prostatic Hyperplasia June 24, 2008

Is seeing a specialist nurse associated with positive experiences of care? The role and value of specialist nurses in prostate cancer care - Abstract April 11, 2008

GU Cancers Symposium - ASCO ASTRO SUO - 2008 - Preliminary Phase II Results of Abiraterone Acetate in Patients with Castration-resistant metastatic Prostate Cancer after Failure of Docetaxel-based Chemotherapy February 15, 2008

GU Cancers Symposium - ASCO ASTRO SUO - 2008 - Preliminary Phase II Results of Abiraterone Acetate in Patients with Castration-resistant metastatic Prostate Cancer after Failure of Docetaxel-based Chemotherapy February 15, 2008

Redefining Clinically Significant Castration Levels in Patients with Prostate Cancer Receiving Continuous Androgen Deprivation Therapy September 20, 2007

Statin Drugs and Risk of Advanced Prostate Cancer March 6, 2007

Page 1437 of 1437